LetterLetter
Febuxostat Use and Safety in Patients With Hyperuricemia
Tomoyuki Kawada
The Journal of Rheumatology June 2022, jrheum.220147; DOI: https://doi.org/10.3899/jrheum.220147
Tomoyuki Kawada
Department of Hygiene and Public Health, Nippon Medical School, Tokyo, Japan. The author declares no conflicts of interest relevant to this article. Address correspondence to Dr. T. Kawada, Department of Hygiene and Public Health, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-Ku, Tokyo 113-8602, Japan. Email: kawada@nms.ac.jp.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Febuxostat Use and Safety in Patients With Hyperuricemia
Tomoyuki Kawada
The Journal of Rheumatology Jun 2022, jrheum.220147; DOI: 10.3899/jrheum.220147